Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
fusion protein Trx/hEGF + H2O
?
the fusion protein Trx/hEGF contains an inter-domain enteropeptidase recognition site
-
?
fusion protein Trx/hIL-13 + H2O
?
the fusion protein Trx/hIL-13 contains an inter-domain enteropeptidase recognition site
-
?
GD4R-4-nitroanilide + H2O
?
-
-
-
?
GDDDDK-4-nitroanilide + H2O
GDDDDK + 4-nitroaniline
-
-
-
?
Gly-(L-Asp)4-L-Lys-2-naphthylamide + H2O
Gly-(L-Asp)4-L-Lys + 2-naphthylamine
-
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
Gly-L-Asp-L-Asp-L-Asp-L-Asp-L-Lys-2-naphthylamide + H2O
Gly-L-Asp-L-Asp-L-Asp-L-Asp-L-Lys + 2-naphthylamine
-
-
-
?
thiobenzyl benzyloxy-carbonyl-L-lysinate + H2O
?
-
-
?
trypsinogen + H2O
trypsin
trypsinogen + H2O
trypsin + ?
Z-Lys-SBzl + H2O
?
-
-
-
?
A4-mutant trypsinogen + H2O
?
-
-
-
-
?
AAVERW-streptavidin-R-phycoerythrin conjugate + H2O
AAVERW + streptavidin-R-phycoerythrin conjugate
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
APFDDDDKIVGG + H2O
?
-
N-terminal dodecapeptides of human cationic trypsinogen
-
-
?
benzoyl-Arg ethyl ester + H2O
benzoyl-Arg + ethanol
-
-
-
-
?
benzyl-L-Arg-2-naphthylamide + H2O
?
-
-
-
-
?
benzyloxycarbonyl-L-alanine-X-L-arginine-p-nitroanilide + H2O
p-nitroaniline + benzyloxycarbonyl-L-alanine-X-L-arginine
-
Z-Ala-X-Arg-pNA
-
-
?
DDDK-SA-PE + H2O
DDDK + SA-PE
-
Asp-Asp-Asp-Asp-Lys-fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
DDRRAG-SA-PE + H2O
DDRRAG + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
DRARVW-SA-PE + H2O
DRARVW + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
EYDRQL-SA-PE + H2O
EYDRQL + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
formyl-Ala-Phe-Arg-4-nitroanilide + H2O
4-nitroaniline + formyl-Ala-Phe-Arg
-
-
-
-
?
formyl-Ala-Phe-Arg-4-nitroanilide + H2O
?
-
a chromogenic peptide substrates
-
-
?
formyl-Ala-Phe-Lys-4-nitroanilide + H2O
4-nitroaniline + formyl-Ala-Phe-Lys
-
-
-
-
?
formyl-Ala-Phe-Lys-4-nitroanilide + H2O
?
-
a chromogenic peptide substrates
-
-
?
G5DKF(NO2)G + H2O
?
-
-
-
-
?
GD4K 2-naphthylamide + H2O
?
-
-
-
-
?
GD4K 7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
GD4KF(NO2)G + H2O
?
-
-
-
-
?
GDDDDK-2-naphthylamide + H2O
GDDDDK + 2-naphthylamine
-
-
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide + H2O
glycyl-tetra-L-aspartyl-L-lysine + beta-naphthylamine
-
-
-
-
?
human cationic trypsinogen + H2O
?
-
-
-
-
?
LTAEEKA + H2O
?
-
-
-
-
?
LTAEEKAAV + H2O
?
-
-
-
-
?
MHGERM-SA-PE + H2O
MHGERM + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
MSGERM-SA-PE + H2O
MSGERM + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester + H2O
N-alpha-benzyloxycarbonyl-L-lysine + benzylmercaptane
-
-
-
-
?
N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester + H2O
N-alpha-benzyloxycarbonyl-L-lysine + phenylmethanethiol
-
-
-
-
?
Nalpha-acetyltrypsinogen + H2O
Nalpha-acetylactivation peptides + trypsin
-
-
-
?
protein C inhibitor + H2O
?
-
-
-
-
?
SERAAAG-SA-PE + H2O
SERAAAG + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
SGDRMW-SA-PE + H2O
SGDRMW + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin, exhibits a 17 fold faster cleavage time than DDDK
-
-
?
SGERMMG-SA-PE + H2O
SGERMMG + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
thiobenzyl benzyloxy-carbonyl-L-lysinate + H2O
3-carboxy-4-nitrophenoxide + ?
-
-
-
-
?
thiobenzyl benzyloxycarbonyl-L-lysinate + H2O
3-carboxy-4-nitrothiophenoxide + ?
-
Z-Lys-SBzl
-
-
?
thioredoxin-human epidermal growth factor fusion protein + H2O
thioredoxin + human epidermal growth factor
-
Trx/hEGF
-
-
?
thioredoxin-tumor necrosis factor-related apoptosis-inducing ligand fusion protein + H2O
thioredoxin + tumor necrosis factor-related apoptosis-inducing ligand
-
trx/TRAIL
enteropeptidase is used to cleave TRAIL from thioredoxin at enzyme-substrate molar ratio of 1 : 30,000
-
?
Tosyl-Arg methyl ester + H2O
Tosyl-Arg + methanol
-
-
-
-
?
tosyl-Lys methyl ester + H2O
tosyl-Lys + methanol
-
-
-
-
?
trypsinogen + H2O
trypsin
-
-
-
-
?
trypsinogen + H2O
trypsin + ?
VDYRFL-SA-PE + H2O
VDYRFL + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
VLDRWM-SA-PE + H2O
VLDRWM + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
VRDYRM-SA-PE + H2O
VRDYRM + SA-PE
-
peptide conjugated to fluorescent probe streptavidin-conjugated phycoerythrin
-
-
?
Z-Ala-Ala-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Ala-Ala-Arg
-
-
-
-
?
Z-Ala-Leu-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Ala-Leu-Arg
-
-
-
-
?
Z-Ala-Met-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Ala-Met-Arg
-
-
-
-
?
Z-Ala-Phe-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Ala-Phe-Arg
-
-
-
-
?
Z-Ala-Trp-Arg-p-nitroanilide + H2O
Z-Ala-Trp-Arg + 4-nitroaniline
-
-
-
-
?
Z-Ala-Tyr-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Ala-Tyr-Arg
-
-
-
-
?
Z-Gly-Pro-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Gly-Pro-Arg
-
-
-
-
?
Z-Pro-Phe-Arg-p-nitroanilide + H2O
p-nitroaniline + Z-Pro-Phe-Arg
-
-
-
-
?
additional information
?
-
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
-
-
-
?
trypsinogen + H2O
trypsin
activation by by endoproteolytic cleavage
-
-
?
trypsinogen + H2O
trypsin
the enzyme cleaves after lysine residue if the Lys is preceded by four Asp and not followed by a Pro, and it shows high specificity of the target site. The light chain represents the catalytic enzyme subunit
-
-
?
trypsinogen + H2O
trypsin + ?
-
-
-
?
trypsinogen + H2O
trypsin + ?
-
-
-
-
?
trypsinogen + H2O
trypsin + ?
-
-
-
?
trypsinogen + H2O
trypsin + ?
cleavage sequence DDDDK-X
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
-
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
-
-
-
-
?
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide + H2O
Gly-Asp-Asp-Asp-Asp-Lys + 2-naphthylamine
-
GD4K-na
-
-
?
Trypsinogen + H2O
?
-
-
-
-
?
Trypsinogen + H2O
?
-
enterokinase deficiency is a distinct clinical entity characterized by diarrhea, failure to thrive, hypoproteinemia, and edema. Acquired enterokinase deficiency may occur in some diffuse small bowel diseases. Steatorhea of cellac sprue may be due partly to the fact that deficiency of secretin and cholecystokinin may interfere with the action of enterokinase
-
-
?
Trypsinogen + H2O
?
-
physiological activator of trypsinogen
-
-
?
Trypsinogen + H2O
?
-
rapid activation of trypsinogen in pancreatic juice. The enzyme has a key permissive role in protein digestion and plays an essential part in the zymogen mechanism that protects the pancreas from self-destruction
-
-
?
trypsinogen + H2O
trypsin + ?
-
-
-
?
trypsinogen + H2O
trypsin + ?
-
-
-
-
?
trypsinogen + H2O
trypsin + ?
-
human cationic trypsinogen is activated much more readily than bovine trypsinogen
-
-
?
trypsinogen + H2O
trypsin + ?
-
specificity for the sequence (Asp)4-Lys-Ile
-
-
?
trypsinogen + H2O
trypsin + ?
-
cleavage after the sequence DDDDK
-
-
?
trypsinogen + H2O
trypsin + ?
-
recognition sequence (Asp)4-Lys
-
-
?
additional information
?
-
-
enteropeptidase cleaves the C-terminal end of the substrate recognition sequence Asp-Asp-Asp-Asp-Lys, D4K. Usage of GD4K-conjugated 7-amino-4-methylcoumarin or GD4K-conjugated 2-naphthylamine as a fluorogenic substrates in the assay for enteropeptidase
-
-
?
additional information
?
-
-
high degree of cleavage specificity is exhibited by enteropeptidase
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acrodermatitis
Congenital diseases of the gastrointestinal tract.
Albuminuria
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease.
alpha,alpha-trehalase deficiency
Possibilities for the cytochemical diagnosis of enzymopathies.
Amyotrophic Lateral Sclerosis
Analysis of circulating protein aggregates as a route of investigation into neurodegenerative disorders.
Anemia
Intestinal enterokinase deficiency.
Arrhythmogenic Right Ventricular Dysplasia
Arrhythmogenic right ventricular dysplasia in a child with congenital enteropeptidase deficiency and hypogammaglobulinaemia.
Biliary Atresia
Role of bile acids in the activation of trypsinogen by enterokinase: disturbance of trypsinogen activation in patients with intrahepatic biliary atresia.
Brain Injuries, Traumatic
In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.
Breast Neoplasms
The SEA module: a new extracellular domain associated with O-glycosylation.
Carcinogenesis
Unraveling mucin domains in cancer and metastasis: when protectors become predators.
Carcinoma
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.
Carcinoma
Immunofluorescent localisation of enterokinase in human small intestine.
Carcinoma
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Celiac Disease
Celiac disease in a patient with a congenital deficiency of intestinal enteropeptidase.
Celiac Disease
Mucosal enterokinase activity in pancreatic insufficiency and celiac disease.
Celiac Disease
The interrelationship of enterokinase and trypsin activities in intractable diarrhea of infancy, celiac disease, and intravenous alimentation.
Cholestasis
Influence of biliary stasis on enterokinase activity in the rat.
Colitis
[Content of enterokinase and pancreatic enzymes in the duodenal juice of patients with chronic colitis and enterocolitis.]
Congenital Abnormalities
Intestinal enterokinase deficiency. Occurrence in two sibs and age dependency of clinical expression.
Cystic Fibrosis
Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Cystic Fibrosis
Effect of pancreozymin and secretin on intraluminal enterokinase, trypsin, and chymotrypsin activities of cystic fibrosis and control children.
Cystic Fibrosis
Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine.
Cystic Fibrosis
Rapid semiquantitative tests for trypsin and chymotrypsin application to screening for cystic fibrosis, enterokinase deficiency and pancreatic hypoplasia in neonates.
Cysts
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen.
Diabetic Nephropathies
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.
Diffuse Axonal Injury
In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.
Enteritis
[Clinical importance of the determination of intestinal dipeptidase and enterokinase activity in patients with chronic enteritis]
Enterocolitis
[Content of enterokinase and pancreatic enzymes in the duodenal juice of patients with chronic colitis and enterocolitis.]
enteropeptidase deficiency
Arrhythmogenic right ventricular dysplasia in a child with congenital enteropeptidase deficiency and hypogammaglobulinaemia.
enteropeptidase deficiency
Celiac disease in a patient with a congenital deficiency of intestinal enteropeptidase.
enteropeptidase deficiency
Congenital diseases of the gastrointestinal tract.
enteropeptidase deficiency
Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine.
enteropeptidase deficiency
Enterokinase deficiency and vitamin B12 absorption.
enteropeptidase deficiency
Enterokinase Deficiency: A Case of Pancreatic Insufficiency.
enteropeptidase deficiency
Enterokinase.
enteropeptidase deficiency
Enteropeptidase: a gene associated with a starvation human phenotype and a novel target for obesity treatment.
enteropeptidase deficiency
Intestinal enterokinase deficiency.
enteropeptidase deficiency
Intestinal enterokinase deficiency. A newly-recognized disorder of protein digestion.
enteropeptidase deficiency
Intestinal enterokinase deficiency. Occurrence in two sibs and age dependency of clinical expression.
enteropeptidase deficiency
Intestinal enteropeptidase deficiency associated with exocrine pancreatic insufficiency.
enteropeptidase deficiency
Isolated congenital enterokinase deficiency. Recent findings and review of the literature.
enteropeptidase deficiency
Malabsorption and growth failure due to intestinal enterokinase deficiency.
enteropeptidase deficiency
Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency.
enteropeptidase deficiency
Novel Compound Heterozygous TMPRSS15 Gene Variants Cause Enterokinase Deficiency.
enteropeptidase deficiency
Primary intestinal enteropeptidase deficiency.
enteropeptidase deficiency
Rapid semiquantitative tests for trypsin and chymotrypsin application to screening for cystic fibrosis, enterokinase deficiency and pancreatic hypoplasia in neonates.
enteropeptidase deficiency
Rare Genetic Diseases with Human Lean and/or Starvation Phenotype Open New Avenues for Obesity and Type II Diabetes Treatment.
enteropeptidase deficiency
The activation of human pancreatic proteinases. Studies on human pancreatic juice and duodenal juice of four children with intestinal enterokinase deficiency.
enteropeptidase deficiency
The interrelationship of enterokinase and trypsin activities in intractable diarrhea of infancy, celiac disease, and intravenous alimentation.
enteropeptidase deficiency
The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
enteropeptidase deficiency
[Congenital enterokinase deficiency]
enteropeptidase deficiency
[Proceedings: Enterokinase deficiency]
enteropeptidase deficiency
[The current status of the problem of enterokinase deficiency]
enteropeptidase deficiency
[Trypsinogen pseudo-deficiency caused by congenital enterokinase deficiency. Clinical study]
enteropeptidase deficiency
[Trypsinogen pseudo-deficiency caused by congenital enterokinase deficiency. Enzyme study]
Exocrine Pancreatic Insufficiency
Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine.
Exocrine Pancreatic Insufficiency
Enterokinase Deficiency: A Case of Pancreatic Insufficiency.
Exocrine Pancreatic Insufficiency
Enteropeptidase (EC 3.4.21.9) in coeliac disease and exocrine pancreatic insufficiency.
Exocrine Pancreatic Insufficiency
Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease.
Exocrine Pancreatic Insufficiency
Intestinal enteropeptidase deficiency associated with exocrine pancreatic insufficiency.
Exocrine Pancreatic Insufficiency
Mucosal enterokinase activity in pancreatic insufficiency and celiac disease.
Fatty Liver
Biliary excretion of enterokinase in rats: studies in alcoholic rats with fatty liver.
Fetal Growth Retardation
Effect of intrauterine growth retardation on the activities of fetal intestinal enzymes in rats.
Foodborne Diseases
[Clinical significance of quantitative determination of enterokinase in feces of patients with food poisoning.]
Gastrointestinal Diseases
Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease.
Giardiasis
[Enterokinase and alkaline phosphatase activity in children with hymenolepiasis and lambliasis]
Herpes Zoster
Initial characterization of an uromodulin-like 1 gene on human chromosome 21q22.3.
Hymenolepiasis
[Enterokinase and alkaline phosphatase activity in children with hymenolepiasis and lambliasis]
Hypoproteinemia
Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine.
Hypoproteinemia
Enterokinase.
Hypoproteinemia
Enteropeptidase, a type II transmembrane serine protease.
Hypoproteinemia
Novel Compound Heterozygous TMPRSS15 Gene Variants Cause Enterokinase Deficiency.
Infections
Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Infections
Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis.
Influenza, Human
Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Insulin Resistance
SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
Insulinoma
Synthetic protease-activated class B GPCRs.
Intestinal Diseases
[Enterokinase and alkaline phosphatase activity in the feces of children in the 1st year of life with acute intestinal diseases and different frequencies of feeding]
Lactose Intolerance
Congenital diseases of the gastrointestinal tract.
Lung Injury
Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury.
Malabsorption Syndromes
[Histochemical study on enterokinase in duodenal and jejunal biopsies of children with malabsorption syndromes]
Malnutrition
Interaction of malnutrition and difluoromethylornithine-induced intestinal mucosal damage: degree of severity and subsequent recovery.
Malnutrition
The effect of early postnatal acquired malnutrition on intestinal growth, disaccharidases and enterokinase.
Malnutrition
The interrelationship of enterokinase and trypsin activities in intractable diarrhea of infancy, celiac disease, and intravenous alimentation.
Metabolic Diseases
Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits.
Metabolic Syndrome
Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome.
Muscle Spasticity
Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways.
Neoplasm Metastasis
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.
Neoplasms
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.
Neoplasms
Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease.
Neoplasms
Enzymatic Noncovalent Synthesis for Mitochondrial Genetic Engineering of Cancer Cells.
Neoplasms
Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum.
Neoplasms
Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture.
Neoplasms
High-level production of human growth hormone in Escherichia coli by a simple recombinant process.
Neoplasms
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen.
Neoplasms
Tandem repeated expression of lunasin gene in Pichia pastoris and its anti-inflammatory activity in vitro.
Neoplasms
The trail of my studies on glycoproteins from enterokinase to tumor markers.
Neoplasms
Unraveling mucin domains in cancer and metastasis: when protectors become predators.
Obesity
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.
Obesity
Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice.
Obesity
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease.
Obesity
Enteropeptidase: a gene associated with a starvation human phenotype and a novel target for obesity treatment.
Obesity
Rare Genetic Diseases with Human Lean and/or Starvation Phenotype Open New Avenues for Obesity and Type II Diabetes Treatment.
Obesity
SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
Pancreatic Diseases
[Isoelectric focusing of pure human pancreatic juice. 1. Examination of patients with and without pancreatic diseases]
Pancreatic Neoplasms
Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease.
Pancreatitis
A model of experimental acute necrotizing pancreatitis.
Pancreatitis
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.
Pancreatitis
Biliary excretion of enterokinase in rats: studies in alcoholic rats with fatty liver.
Pancreatitis
Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
Pancreatitis
Catalytically active enterokinase in human bile.
Pancreatitis
Change of pancreatic enzymes, pancreatic stone protein (PSP), and plasma alpha(2)-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice.
Pancreatitis
Enterokinase in cerulein pancreatitis.
Pancreatitis
Enterokinase induced pancreatitis: its prevention with Trasylol and soybean trypsin inhibitor.
Pancreatitis
Enterokinase induces severe necrosis and rapid mortality in cerulein pancreatitis: characterization of a novel noninvasive rat model of necro-hemorrhagic pancreatitis.
Pancreatitis
Enterokinase.
Pancreatitis
Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis.
Pancreatitis
Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs.
Pancreatitis
Interstitial protease activation is the central event in progression to necrotizing pancreatitis.
Pancreatitis
Intraduct enterokinase is lethal in rats with experimental bile-salt pancreatitis.
Pancreatitis
Loss of Bace1 in mice does not alter the severity of caerulein induced pancreatitis.
Pancreatitis
Methylene blue improves hemodynamic shock but increases lipoperoxidation in severe acute pancreatitis pig model.
Pancreatitis
Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis.
Pancreatitis
Pancreatic duct and microvascular permeability to macromolecules. The relation to acute pancreatitis.
Pancreatitis
Pancreatitis following the intraductal injection of partially purified enterokinase in dogs.
Pancreatitis
Role of SCO-792, A Novel Enteropeptidase Inhibitor, In the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Pancreatitis
Somatosensory evoked potentials as predictor of systemic inflammatory response syndrome in pigs?
Pancreatitis
The generation of lysolecithin by enterokinase in trypsinogen prophospholipase A2 lecithin mixtures, and its relevance to the pathogenesis of acute necrotising pancreatitis.
Pancreatitis
The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
Pancreatitis
Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a beta-agonist, and antibiotics.
Pancreatitis
Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury.
Pancreatitis
[Change in the enterokinase and alkaline phosphatase activity in the duodenal contents in acute experimental pancreatitis in dogs]
Pancreatitis
[Hydrolysis by enteropeptidase of nonspecific (model) peptide sequences and possible physiological role of this phenomenon]
Pancreatitis, Acute Hemorrhagic
Effect of chlorophyll-a, fluorouracil, and pituitrin on experimental acute pancreatitis.
Pancreatitis, Acute Hemorrhagic
Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.
Pancreatitis, Acute Necrotizing
Intraduct enterokinase is lethal in rats with experimental bile-salt pancreatitis.
Pancreatitis, Alcoholic
Enteropeptidase levels in duodenal juice of normal subjects and patients with gastrointestinal disease.
Pancreatitis, Chronic
Enteropeptidase, a type II transmembrane serine protease.
Pancreatitis, Chronic
Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis.
Pancreatitis, Chronic
[Isoelectric focusing of pure human pancreatic juice. 1. Examination of patients with and without pancreatic diseases]
Paralysis
Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways.
Protein-Energy Malnutrition
Enterokinase and disaccharidase activities of the small intestinal mucosa in infants with protein-energy malnutrition and in normal infants.
Renal Insufficiency, Chronic
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease.
Skin Diseases
[Enterokinase activity of the intestine in several skin diseases]
Squamous Cell Carcinoma of Head and Neck
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Starvation
Enteropeptidase: a gene associated with a starvation human phenotype and a novel target for obesity treatment.
Steatorrhea
Enterokinase.
Stomach Neoplasms
Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture.
Thrombosis
cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects.
Trichuriasis
[Microparasitocenosis of the intestines and the activity of intestinal enzymes in patients with trichocephaliasis during treatment]
Virus Diseases
Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00258 - 0.018
GD4R-4-nitroanilide
0.0179 - 0.276
GDDDDK-4-nitroanilide
0.123 - 0.16
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
0.108
Gly-L-Asp-L-Asp-L-Asp-L-Asp-L-Lys-2-naphthylamide
at pH 8.0 and 37°C
0.14
thiobenzyl benzyloxy-carbonyl-L-lysinate
pH 8.4, 37°C
0.0021
A4-mutant trypsinogen
-
37 °C, 100 mM Tris-HCl (pH 8.0), 1 mM CaCl2, 120 nM soybean trypsin inhibitor, 0.13 nM human enteropeptidase
-
0.0647
APFDDDDKIVGG
-
EP light chain
0.076
formyl-Ala-Phe-Arg-4-nitroanilide
-
pH 8.4, 25°C
0.167
formyl-Ala-Phe-Lys-4-nitroanilide
-
pH 8.4, 25°C
0.5 - 0.6
GD4K 2-naphthylamide
-
pH 8.4, 35°C
0.025
GD4K 7-amido-4-methylcoumarin
-
pH 8.4, 35°C
0.16
GD4KF(NO2)G
-
50 mM Ca2+, pH 8.0, 37°C
0.019 - 0.02
GDDDDK-2-naphthylamide
0.034
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
-
pH 8.4, 37°C
0.034 - 0.08
Gly-Asp-Asp-Asp-Asp-Lys-naphthylamide
0.2 - 0.525
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
0.0014 - 0.0072
human cationic trypsinogen
-
596
N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester +
-
37°C, pH 8.0
-
0.076
N-formyl-Ala-Phe-Arg-4-nitroanilide
-
-
0.167
N-formyl-Ala-Phe-Lys-4-nitroanilide
-
-
0.14
thiobenzyl benzyloxy-carbonyl-L-lysinate
-
pH 8.4, 25°C
0.14
thiobenzyl benzyloxycarbonyl-L-lysinate
-
-
0.0072
Trypsinogen
-
human trypsinogen
0.356
Z-Ala-Ala-Arg-nitroanilide
-
-
0.234
Z-Ala-Leu-Arg-nitroanilide
-
-
0.42
Z-Ala-Met-Arg-nitroanilide
-
-
0.067
Z-Ala-Phe-Arg-nitroanilide
-
-
0.24
Z-Ala-Trp-Arg-nitroanilide
-
-
0.109
Z-Ala-Tyr-Arg-nitroanilide
-
-
0.091
Z-Gly-Pro-Arg-nitroanilide
-
-
0.265
Z-Pro-Phe-Arg-nitroanilide
-
-
0.00258
GD4R-4-nitroanilide
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.00629
GD4R-4-nitroanilide
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.018
GD4R-4-nitroanilide
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.0179
GDDDDK-4-nitroanilide
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.0298
GDDDDK-4-nitroanilide
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.276
GDDDDK-4-nitroanilide
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.123
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
value obtained by fluorescence spectroscopy, pH not specified in the publication, at 37°C
0.143
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
value obtained by impedance spectroscopy, pH not specified in the publication, at 37°C
0.16
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
pH 8.4, 37°C
0.165
Z-Lys-SBzl
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.172
Z-Lys-SBzl
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.19
Z-Lys-SBzl
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.019
GDDDDK-2-naphthylamide
-
phage-bound enteropeptidase catalytic subunit, in 25 mM Tris-HCl (pH 8.4), at 37°C
0.02
GDDDDK-2-naphthylamide
-
soluble enzyme, in 25 mM Tris-HCl (pH 8.4), at 37°C
0.034
Gly-Asp-Asp-Asp-Asp-Lys-naphthylamide
-
in presence of 0.02 mM CaCl2
0.08
Gly-Asp-Asp-Asp-Asp-Lys-naphthylamide
-
in presence of 1mM EDTA
0.2
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
-
50 mM Ca2+, pH 8.0, 37°C
0.525
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
-
pH 8.0, 37°C
0.0014
human cationic trypsinogen
-
37 °C, 100 mM Tris-HCl pH 8.0, 1mM CaCl2, 120 nM soybean trypsin inhibitor, 0.13 nM human enteropeptidase
-
0.0072
human cationic trypsinogen
-
25 °C, 28 mM sodium succinate (pH 5.6), 10 mM CaCl2
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
42 - 49
GD4R-4-nitroanilide
122 - 148
GDDDDK-4-nitroanilide
98 - 121
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
58.38
Gly-L-Asp-L-Asp-L-Asp-L-Asp-L-Lys-2-naphthylamide
at pH 8.0 and 37°C
133
thiobenzyl benzyloxy-carbonyl-L-lysinate
pH 8.4, 37°C
11.2
A4-mutant trypsinogen
-
37 °C, 100 mM Tris-HCl (pH 8.0), 1 mM CaCl2, 120 nM soybean trypsin inhibitor, 0.13 nM enteropeptidase
-
23.5
formyl-Ala-Phe-Arg-4-nitroanilide
-
pH 8.4, 25°C
18.2
formyl-Ala-Phe-Lys-4-nitroanilide
-
pH 8.4, 25°C
24.9
GD4K 2-naphthylamide
-
pH 8.4, 35°C
64.8
GD4K 7-amido-4-methylcoumarin
-
pH 8.4, 35°C
92 - 115
GDDDDK-2-naphthylamide
118
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
-
pH 8.4, 37°C
0.97 - 21.5
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
2.3 - 35.1
human cationic trypsinogen
-
0.07
LTAEEKA
-
pH 8.0, 37°C
111
N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester
-
37°C, pH 8.0
133
thiobenzyl benzyloxy-carbonyl-L-lysinate
-
pH 8.4, 25°C
2.8
Trypsinogen
-
human trypsinogen
42
GD4R-4-nitroanilide
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
45
GD4R-4-nitroanilide
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
49
GD4R-4-nitroanilide
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
122
GDDDDK-4-nitroanilide
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
135
GDDDDK-4-nitroanilide
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
148
GDDDDK-4-nitroanilide
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
98
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
value obtained by fluorescence spectroscopy, pH not specified in the publication, at 37°C
115
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
pH 8.4, 37°C
121
Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide
value obtained by impedance spectroscopy, pH not specified in the publication, at 37°C
319
Z-Lys-SBzl
mutant enzyme Y174R, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
336
Z-Lys-SBzl
wild type enzyme, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
354
Z-Lys-SBzl
mutant enzyme R96Q, in 100 mM Tris, 0.02 mM CaCl2, 0.01% (v/v) Triton X-100, 10% (v/v) DMSO, pH 8.0, at 22°C
0.97
G5DKF(NO2)G
-
50 mM Ca2+, pH 8.0, 37°C
17.33
G5DKF(NO2)G
-
50 mM Ca2+, pH 8.0, 37°C
0.99
GD4KF(NO2)G
-
50 mM Ca2+, pH 8.0, 37°C
17.83
GD4KF(NO2)G
-
50 mM Ca2+, pH 8.0, 37°C
92
GDDDDK-2-naphthylamide
-
soluble enzyme, in 25 mM Tris-HCl (pH 8.4), at 37°C
115
GDDDDK-2-naphthylamide
-
phage-bound enteropeptidase catalytic subunit, in 25 mM Tris-HCl (pH 8.4), at 37°C
0.97
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
-
50 mM Ca2+, pH 8.0, 37°C
16.67
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
-
50 mM Ca2+, pH 8.0, 37°C
21.5
glycyl-tetra-L-aspartyl-L-lysine beta-naphthylamide
-
pH 8.0, 37°C
2.3
human cationic trypsinogen
-
25°C, 28 mM sodium succinate (pH 5.6), 10 mM CaCl2
-
2.3
human cationic trypsinogen
-
0.00036 1/sec/mg, incubates 30 min at 37°C, pH 9.0, spectrophotometrically measured at 415 nm
-
35.1
human cationic trypsinogen
-
37 °C, 100 mM Tris-HCl pH 8.0, 1mM CaCl2, 120 nM soybean trypsin inhibitor, 0.13 nM enteropeptidase
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Grant, D.A.W.; Hermon-Taylor, J.
Enterokinase
Methods Enzym. Anal. , 3rd Ed. (Bergmeyer, H. U. , ed. )
5
143-155
1984
Bos taurus, Homo sapiens, Sus scrofa
-
brenda
Magee, A.I.; Grant, D.A.W.; Hermon-Taylor, J.; Offord, R.E.
Specific one-stage method for assay of enterokinase activity by release of radiolabelled activation peptides from alpha-N-[3H]acetyl-trypsinogen and the effect of calcium ions on the enzyme activity
Biochem. J.
197
239-244
1981
Homo sapiens
brenda
Brodrick, J.W.; Largman, C.; Hsiang, M.W.; Johnson, J.H.; Geokas, M.C.
Structural basis for the specific activation of human enteropeptidase
J. Biol. Chem.
253
2737-2742
1978
Homo sapiens, Sus scrofa
brenda
Grant, D.A.W.; Hermon-Taylor, J.
The purification of human enterokinase by affinity chromatography and immunoadsorption. Some observations on its molecular characteristics and comparisons with the pig enzyme
Biochem. J.
155
243-254
1976
Homo sapiens, Sus scrofa
brenda
Miyoshi, Y.; Onishi, T.; Sano, T.; Komi, N.
Monoclonal antibody against human enterokinase and immunohistochemica localization of the enzyme
Gastroenterol. Jpn.
25
320-327
1990
Homo sapiens
brenda
Mann, N.S.; Mann, S.K.
Enterokinase
Proc. Soc. Exp. Biol. Med.
206
114-118
1994
Homo sapiens
brenda
Light, A.; Janska, G.
Enterokinase (enteropeptidase): comparative aspects
Trends Biochem. Sci.
14
110-112
1989
Bos taurus, Homo sapiens, Sus scrofa
brenda
Gasparian, M.E.; Ostapchenko, V.G.; Schulga, A.A.; Dolgikh, D.A.; Kirpichnikov, M.P.
Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli
Protein Expr. Purif.
31
133-139
2003
Homo sapiens (P98073), Homo sapiens
brenda
Mikhailova, A.G.; Likhareva, V.V.; Prudchenko, I.A.; Rumsh, L.D.
Effect of calcium ions on enteropeptidase catalysis
Biochemistry (Moscow)
70
1129-1135
2005
Homo sapiens
brenda
Nemoda, Z.; Sahin-Toth, M.
The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition
J. Biol. Chem.
280
29645-29652
2005
Bos taurus, Homo sapiens
brenda
Gasparian, M.E.; Ostapchenko, V.G.; Dolgikh, D.A.; Kirpichnikov, M.P.
Biochemical characterization of human enteropeptidase light chain
Biochemistry (Moscow)
71
113-119
2006
Bos taurus, Homo sapiens
brenda
Gasparian, M.E.; Ostapchenko, V.G.; Yagolovich, A.V.; Tsygannik, I.N.; Chernyak, B.V.; Dolgikh, D.A.; Kirpichnikov, M.P.
Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase
Biotechnol. Lett.
29
1567-1573
2007
Homo sapiens
brenda
Boulware, K.T.; Daugherty, P.S.
Protease specificity determination by using cellular libraries of peptide substrates (CLiPS)
Proc. Natl. Acad. Sci. USA
103
7583-7588
2006
Homo sapiens
brenda
Mikhailova, A.G.; Likhareva, V.V.; Teich, N.; Rumsh, L.D.
The ways of realization of high specificity and efficiency of enteropeptidase
Protein Pept. Lett.
14
227-232
2007
Homo sapiens, Bos taurus (Q6B4R4), Bos taurus
brenda
Makarova, A.M.; Gorbacheva, L.R.; Savinkova, I.V.; Mikhailova, A.G.; Rumsh, L.D.; Pinelis, V.G.; Strukova, S.M.
Effect of enteropeptidase on survival of cultured hippocampal neurons under conditions of glutamate toxicity
Biochemistry (Moscow)
75
1153-1159
2010
Bos taurus, Homo sapiens
brenda
Choi, M.G.; Lee, E.; Chung, H.S.; Jang, S.H.; Lee, C.
A fluorogenic method for measuring enteropeptidase activity: spectral shift in the emission of GD4K-conjugated 7-amino-4-methylcoumarin
BMB Rep.
44
458-461
2011
Homo sapiens
brenda
Pepeliaev, S.; Krahulec, J.; ?erny, Z.; Jilkova, J.; Tlusta, M.; Dostalova, J.
High level expression of human enteropeptidase light chain in Pichia pastoris
J. Biotechnol.
156
67-75
2011
Homo sapiens (P98073), Homo sapiens
brenda
Simeonov, P.; Berger-Hoffmann, R.; Hoffmann, R.; Straeter, N.; Zuchner, T.
Surface supercharged human enteropeptidase light chain shows improved solubility and refolding yield
Protein Eng. Des. Sel.
24
261-268
2011
Homo sapiens (P98073), Homo sapiens
brenda
Gasparian, M.E.; Bychkov, M.L.; Dolgikh, D.A.; Kirpichnikov, M.P.
Strategy for improvement of enteropeptidase efficiency in tag removal processes
Protein Expr. Purif.
79
191-196
2011
Bos taurus, Homo sapiens
brenda
Gasparian, M.E.; Bobik, T.V.; Kim, Y.V.; Ponomarenko, N.A.; Dolgikh, D.A.; Gabibov, A.G.; Kirpichnikov, M.P.
Heterogeneous catalysis on the phage surface: Display of active human enteropeptidase
Biochimie
95
2076-2081
2013
Homo sapiens
brenda
Ostapchenko, V.G.; Gasparian, M.E.; Kosinsky, Y.A.; Efremov, R.G.; Dolgikh, D.A.; Kirpichnikov, M.P.
Dissecting structural basis of the unique substrate selectivity of human enteropeptidase catalytic subunit
J. Biomol. Struct. Dyn.
30
62-73
2012
Bos taurus, Homo sapiens
brenda
Jirickova, K.; Gal, M.; Krahulec, J.; Hives, J.
Electrochemical determination of basic biochemical properties of enzyme enterokinase
Monatsh. Chem.
146
755-759
2015
Homo sapiens (P98073)
-
brenda
Prohaska, T.A.; Wahlmueller, F.C.; Furtmueller, M.; Geiger, M.
Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase
PLoS ONE
7
e39262
2012
Homo sapiens
brenda
Smith, E.T.; Johnson, D.A.
Human enteropeptidase light chain: bioengineering of recombinants and kinetic investigations of structure and function
Protein Sci.
22
577-585
2013
Homo sapiens (P98073), Homo sapiens
brenda
Simeonov, P.; Zahn, M.; Straeter, N.; Zuchner, T.
Crystal structure of a supercharged variant of the human enteropeptidase light chain
Proteins
80
1907-1910
2012
Homo sapiens (P98073), Homo sapiens
brenda
Melicherova, K.; Krahulec, J.; Safranek, M.; Liskova, V.; Hopkova, D.; Szeliova, D.; Turna, J.
Optimization of the fermentation and downstream processes for human enterokinase production in Pichia pastoris
Appl. Microbiol. Biotechnol.
101
1927-1934
2017
Homo sapiens (P98073), Homo sapiens
brenda
Niu, L.; Li, J.; Ji, X.; Yang, B.
Efficient expression and purification of recombinant human enteropeptidase light chain in Escherichia coli
Braz. Arch. Biol. Technol.
58
216-221
2015
Homo sapiens (P98073)
-
brenda
Hayashi, H.; Kubo, Y.; Izumida, M.; Takahashi, E.; Kido, H.; Sato, K.; Yamaya, M.; Nishimura, H.; Nakayama, K.; Matsuyama, T.
Enterokinase enhances influenza A virus infection by activating trypsinogen in human cell lines
Front. Cell. Infect. Microbiol.
8
91
2018
Homo sapiens (P98073), Homo sapiens
brenda